Floatz logo

Amifostine

Extragonadal Germ Cell Tumor

Children's Oncology GroupSmall moleculePhase 2Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Extragonadal Germ Cell Tumor cohort.

Asset / SponsorPhaseRating
FILGRASTIM
City of Hope Medical Center
Phase 2BBB
ETOPOSIDE
City of Hope Medical Center
Phase 3BBB
CIS-DIAMMINEDICHLOROPLATINUM II
Memorial Sloan Kettering Cancer Center
Phase 3BB
Carboplatin
City of Hope Medical Center
Phase 3BB
Cyclophosphamide
UNICANCER
Phase 2BB

View all 34 →

Same molecule, other indications

Amifostine is also rated in:

cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
lung cancerDormant
BB
Indicative ·
66 / 100
View asset →
radiation injuryDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →